Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches-Reference-Cited by-同舟云学术

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches

Published:2019-06-28 Issue: Volume:9 Page:
ISSN:2235-2988
Container-title:Frontiers in Cellular and Infection Microbiology
language:
Short-container-title:Front. Cell. Infect. Microbiol.

Author:

Rebello Karina M.,Andrade-Neto Valter V.,Gomes Claudia Regina B.,de Souza Marcos Vinícius N.,Branquinha Marta H.,Santos André L. S.,Torres-Santos Eduardo Caio,d'Avila-Levy Claudia M.

Funder

Fundação Oswaldo Cruz

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiiçoamento de Pessoal de Nível Superior

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference47 articles.

1. Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients;Adriaensen;Front. Immunol.,2017

2. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases;Agostoni;Infection,1998

3. The relationship between leishmaniasis and AIDS: the second 10 years;Alvar;Clin. Microbiol. Rev.,2008

4. Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole;Andrade-Neto;Parasit. Vectors,2016

5. Complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the leishmania metabolome caused by miltefosine;Armitage;Antimicrob. Agents Chemother.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring host epigenetic enzymes as targeted therapies for visceral leishmaniasis: in silico design and in vitro efficacy of KDM6B and ASH1L inhibitors;Molecular Diversity;2024-03-24

2. In Vitro and In Vivo Effects of Conventional and Chitosan Nanoparticle-Encapsulated Miltefosine Drug for Treatment of Cutaneous Leishmaniasis;The 2nd International Electronic Conference on Biomedicines;2023-04-07

3. Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022);Expert Opinion on Therapeutic Patents;2023-03-04

4. Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis;International Journal of Molecular Sciences;2023-01-13

5. Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review;Frontiers in Bioengineering and Biotechnology;2022-12-14